BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 15715475)

  • 1. Extravascular transport of drugs in tumor tissue: effect of lipophilicity on diffusion of tirapazamine analogues in multicellular layer cultures.
    Pruijn FB; Sturman JR; Liyanage HD; Hicks KO; Hay MP; Wilson WR
    J Med Chem; 2005 Feb; 48(4):1079-87. PubMed ID: 15715475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicellular resistance to tirapazamine is due to restricted extravascular transport: a pharmacokinetic/pharmacodynamic study in HT29 multicellular layer cultures.
    Hicks KO; Pruijn FB; Sturman JR; Denny WA; Wilson WR
    Cancer Res; 2003 Sep; 63(18):5970-7. PubMed ID: 14522924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxygen dependence and extravascular transport of hypoxia-activated prodrugs: comparison of the dinitrobenzamide mustard PR-104A and tirapazamine.
    Hicks KO; Myint H; Patterson AV; Pruijn FB; Siim BG; Patel K; Wilson WR
    Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):560-71. PubMed ID: 17869669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia-selective 3-alkyl 1,2,4-benzotriazine 1,4-dioxides: the influence of hydrogen bond donors on extravascular transport and antitumor activity.
    Hay MP; Pchalek K; Pruijn FB; Hicks KO; Siim BG; Anderson RF; Shinde SS; Phillips V; Denny WA; Wilson WR
    J Med Chem; 2007 Dec; 50(26):6654-64. PubMed ID: 18052317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic/pharmacodynamic model-guided identification of hypoxia-selective 1,2,4-benzotriazine 1,4-dioxides with antitumor activity: the role of extravascular transport.
    Hay MP; Hicks KO; Pruijn FB; Pchalek K; Siim BG; Wilson WR; Denny WA
    J Med Chem; 2007 Dec; 50(25):6392-404. PubMed ID: 18001018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extravascular transport of the DNA intercalator and topoisomerase poison N-[2-(Dimethylamino)ethyl]acridine-4-carboxamide (DACA): diffusion and metabolism in multicellular layers of tumor cells.
    Hicks KO; Pruijn FB; Baguley BC; Wilson WR
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1088-98. PubMed ID: 11356933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of three-dimensional tissue cultures to model extravascular transport and predict in vivo activity of hypoxia-targeted anticancer drugs.
    Hicks KO; Pruijn FB; Secomb TW; Hay MP; Hsu R; Brown JM; Denny WA; Dewhirst MW; Wilson WR
    J Natl Cancer Inst; 2006 Aug; 98(16):1118-28. PubMed ID: 16912264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extravascular diffusion of tirapazamine: effect of metabolic consumption assessed using the multicellular layer model.
    Hicks KO; Fleming Y; Siim BG; Koch CJ; Wilson WR
    Int J Radiat Oncol Biol Phys; 1998 Oct; 42(3):641-9. PubMed ID: 9806526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of delivery and metabolism of tirapazamine to tumour tissue using the multilayered cell culture model.
    Kyle AH; Minchinton AI
    Cancer Chemother Pharmacol; 1999; 43(3):213-20. PubMed ID: 9923551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic/pharmacodynamic modeling identifies SN30000 and SN29751 as tirapazamine analogues with improved tissue penetration and hypoxic cell killing in tumors.
    Hicks KO; Siim BG; Jaiswal JK; Pruijn FB; Fraser AM; Patel R; Hogg A; Liyanage HD; Dorie MJ; Brown JM; Denny WA; Hay MP; Wilson WR
    Clin Cancer Res; 2010 Oct; 16(20):4946-57. PubMed ID: 20732963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationships of 1,2,4-benzotriazine 1,4-dioxides as hypoxia-selective analogues of tirapazamine.
    Hay MP; Gamage SA; Kovacs MS; Pruijn FB; Anderson RF; Patterson AV; Wilson WR; Brown JM; Denny WA
    J Med Chem; 2003 Jan; 46(1):169-82. PubMed ID: 12502371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxygen dependence of the metabolic activation and cytotoxicity of tirapazamine: implications for extravascular transport and activity in tumors.
    Hicks KO; Siim BG; Pruijn FB; Wilson WR
    Radiat Res; 2004 Jun; 161(6):656-66. PubMed ID: 15161354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA-targeted 1,2,4-benzotriazine 1,4-dioxides: potent analogues of the hypoxia-selective cytotoxin tirapazamine.
    Hay MP; Pruijn FB; Gamage SA; Liyanage HD; Kovacs MS; Patterson AV; Wilson WR; Brown JM; Denny WA
    J Med Chem; 2004 Jan; 47(2):475-88. PubMed ID: 14711317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective potentiation of the hypoxic cytotoxicity of tirapazamine by its 1-N-oxide metabolite SR 4317.
    Siim BG; Pruijn FB; Sturman JR; Hogg A; Hay MP; Brown JM; Wilson WR
    Cancer Res; 2004 Jan; 64(2):736-42. PubMed ID: 14744792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicellular membranes as an in vitro model for extravascular diffusion in tumours.
    Cowan DS; Hicks KO; Wilson WR
    Br J Cancer Suppl; 1996 Jul; 27():S28-31. PubMed ID: 8763841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transport kinetics of four- and six-coordinate platinum compounds in the multicell layer tumour model.
    Modok S; Scott R; Alderden RA; Hall MD; Mellor HR; Bohic S; Roose T; Hambley TW; Callaghan R
    Br J Cancer; 2007 Jul; 97(2):194-200. PubMed ID: 17579620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipophilicity of novel antitumour and analgesic active 8-aryl-2,6,7,8-tetrahydroimidazo[2,1-c][1,2,4]triazine-3,4-dione derivatives determined by reversed-phase HPLC and computational methods.
    Sztanke K; Markowski W; Swieboda R; Polak B
    Eur J Med Chem; 2010 Jun; 45(6):2644-9. PubMed ID: 20172631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonlinear dependence of biological activity on hydrophobic character: the bilinear model.
    Kubinyi H
    Farmaco Sci; 1979 Mar; 34(3):248-76. PubMed ID: 43264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High lipophilicity decreases drug transport across intestinal epithelial cells.
    Wils P; Warnery A; Phung-Ba V; Legrain S; Scherman D
    J Pharmacol Exp Ther; 1994 May; 269(2):654-8. PubMed ID: 8182532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of the antivascular agent ZD6126 with hypoxic cytotoxin treatment, with reference to the effect on quiescent tumor cells and the dependency on p53 status of tumor cells.
    Masunaga S; Nagasawa H; Uto Y; Hori H; Ohnishi K; Takahashi A; Ohnishi T; Suzuki M; Nagata K; Kinashi Y; Ono K
    Oncol Rep; 2005 Aug; 14(2):393-400. PubMed ID: 16012721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.